Clinical Trials Logo

Clinical Trial Summary

Superficial vein thrombosis (SVT) and venous thromboembolism (VTE) are related entities. Only in the last years a series of observational studies mainly conducted in France could show that ´isolated SVT´ (without concomitant deep vein thrombosis and/or pulmonary embolism) is in fact not a benign and spontaneously healing disease but bears a potential for severe thromboembolic complications once not treated adequately. INSIGHTS-SVT study aims at collecting representative data on the current management and outcomes of SVT in Germany under real-life conditions. It will document the implementation of the recently issued national SVT guidelines issued by the Society for Angiology (DGA) and the Society for Phlebology (DGP).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02699151
Study type Observational
Source GWT-TUD GmbH
Contact
Status Completed
Phase
Start date April 14, 2016
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Withdrawn NCT04136561 - Novel Strategy to Encourage Early Removal of Central Venous Catheters N/A
Completed NCT01501175 - Incidence of Superficial Vein Thrombosis N/A
Completed NCT05001776 - Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein Phase 4
Completed NCT01499953 - Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux Phase 3